The Netherlands, 30 July 2025 Vopak reports strong HY1 2025 results driven by a resilient portfolio and is increasing FY 2025 outlook  Key highlights HY1 2025 Improve Net profit -including exceptional items- in HY1 2025 of EUR 319 million and EPS of EUR 2.74, increased by 58% year-on-yearProportional EBITDA -excluding exceptional items1- in HY1 2025 of EUR 615 million an increase of 3% year-on-yearSuccessful listing of our joint venture AVTL in India, generated a EUR 111 million exceptional gainSuccessfully ...

Novocure Limited (NASDAQ: NVCR ) develops wearables that generate Tumor Treating Fields (TTFields), which can be used for treating aggressive cancers. In that sense, NVCR features approved devices like Optune and Optune Gio for treating glioblastoma (GBM). NVCR’s Optune Lua instead helpsMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athen ...

I focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimately, I aim to identify companies with solid fundamentals, sustainable competitive advantages, and growth potential.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the compa ...

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2025) - FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ0) (the "Company" or First Andes") today announced that it has closed the final tranche of its previously announced non-brokered private placement financing (see news release dated July 3, 2025, July 15, 2025 and July 16, 2025) (the "Offering") by issuing 3,000,000 units ("Units") at a price of $0.10 CAD per unit for gross proceeds of $300,000. Under the entire Offering, the Compan ...

Starbucks' grab-and-go stores are on the way out. On Tuesday, the coffee store chain announced that it's discontinuing its mobile order-only store model.Around 80 to 90 pickup-only locations in the US, many of which are located in office buildings and offer no seating, will be phased out, said CEO Brian Niccol. Some will be converted into full-service stores with room to linger. "These stores felt too transactional and didn't deliver the warmth or human connection our customers expect," Niccol told invest ...

BlackRock Science and Technology Trust (NYSE: BST ) is an attractive hybrid vehicle, capable of combining a high yield due to a fixed monthly dividend and annual yield of around 7.8% and the growth potential of leading global tech companies. WeUnbiased Alpha is a Swiss Fintech startup consulting institutional investors across the globe in Quantitative Trading and Systematic Strategies. The company develops software solutions, cloud services and API-based data science algorithms for data science, with a focu ...

Starbucks isn't giving up on its China dream and is seeking a helping hand to run its stores there. CEO Brian Niccol said in an earnings call on Tuesday that the Seattle-based coffee chain is looking for a local partner to manage its stores in China. The country is Starbucks' second-largest market after the US, and has seen sales stagnate in recent quarters.He said Starbucks is evaluating a pool of 20 interested parties who wish to partner with it. "What this is about is how do we ensure that the Starbuck ...

公司评级调整 - 分析师在4月将对Keurig Dr Pepper的评级下调至持有 主要由于关税不确定性 利润率疲软以及咖啡需求趋势逆转 [1] - 第二季度出现改善迹象 特别是美国咖啡胶囊业务表现强劲 [1] 投资策略 - 投资理念结合价值投资原则与长期增长视角 注重以低于内在价值的价格买入优质公司并长期持有 [1] - 核心能力包括基本面分析及识别具有长期增长潜力的低估企业 [1] （注：文档2和文档3内容均为披露声明 与公司及行业分析无关 已按要求跳过）

I had a buy rating for BE Semiconductor Industries N.V. ( OTC:BESIY ) previously, as I thought the stock had very attractive upside given its position to ride on the AI demand wave. After reviewing 2Q25, I remain confident. WhileI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit ec ...

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts an ...